Pathogenesis and Current Treatment of Osteosarcoma: Perspectives for Future Therapies

le Rathore, Richa, Van Tine, Brian A.
Foilsithe in J Clin Med (2021)

Therapeutic arginine starvation in ASS1-deficient cancers inhibits the Warburg effect

le Kremer, Jeff C., Van Tine, Brian A.
Foilsithe in Mol Cell Oncol (2017)

PHGDH as a mechanism for resistance in metabolically-driven cancers

le Rathore, Richa, Schutt, Charles R., Van Tine, Brian A.
Foilsithe in Cancer Drug Resist (2020)

ER and PI3K independently modulate endocrine resistance in ER positive breast cancer

le Van Tine, Brian A., Crowder, Robert J., Ellis, Matthew J.
Foilsithe 2011

Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review

le Oppelt, Peter J., Hirbe, Angela C., Van Tine, Brian A.
Foilsithe in J Gastrointest Oncol (2017)

Neoadjuvant Ifosfamide and Epirubicin in the Treatment of Malignant Peripheral Nerve Sheath Tumors

le Hirbe, Angela C., Cosper, Pippa F., Dahiya, Sonika, Van Tine, Brian A.
Foilsithe in Sarcoma (2017)

mRNA Splicing Regulates Human Papillomavirus Type 11 E1 Protein Production and DNA Replication

le Deng, Wentao, Jin, Ge, Lin, Biing-Yuan, Van Tine, Brian A., Broker, Thomas R., Chow, Louise T.
Foilsithe 2003

Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy

le Schenone, Aaron D, Luo, Jingqin, Montgomery, Luke, Morgensztern, Daniel, Adkins, Douglas R, Van Tine, Brian A
Foilsithe 2014

Human Papillomavirus DNA Replication Compartments in a Transient DNA Replication System

le Swindle, C. Scott, Zou, Nianxiang, Van Tine, Brian A., Shaw, George M., Engler, Jeffrey A., Chow, Louise T.
Foilsithe 1999

Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis

le Dong, Yiyu, Van Tine, Brian A, Oyama, Toshinao, Wang, Patricia I, Cheng, Emily H, Hsieh, James J
Foilsithe in Cell Res (2014)

Intracellular arginine-dependent translation sensor reveals the dynamics of arginine starvation response and resistance in ASS1-negative cells

le Rogers, Leonard C., Zhou, Jing, Baker, Adriana, Schutt, Charles R., Panda, Prashanta K., Van Tine, Brian A.
Foilsithe in Cancer Metab (2021)

Development of (89)Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications

le Lange, Sara E.S., Zheleznyak, Alex, Studer, Matthew, O'Shannessy, Daniel J., Lapi, Suzanne E., Van Tine, Brian A.
Foilsithe in Oncotarget (2016)

Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience

le Cosper, Pippa F., Olsen, Jeffrey, DeWees, Todd, Van Tine, Brian A., Hawkins, William, Michalski, Jeff, Zoberi, Imran
Foilsithe in Radiat Oncol (2017)

BRAF(V600E) mutation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors

le Hirbe, Angela C., Pekmezci, Melike, Dahiya, Sonika, Apicelli, Anthony J., Van Tine, Brian A., Perry, Arie, Gutmann, David H.
Foilsithe 2014

Dynamic Localization of the Human Papillomavirus Type 11 Origin Binding Protein E2 through Mitosis While in Association with the Spindle Apparatus

le Dao, Luan D., Duffy, Aaron, Van Tine, Brian A., Wu, Shwu-Yuan, Chiang, Cheng-Ming, Broker, Thomas R., Chow, Louise T.
Foilsithe 2006

Multi-platform profiling of over 2000 sarcomas: Identification of biomarkers and novel therapeutic targets

le Movva, Sujana, Wen, Wenhsiang, Chen, Wangjuh, Millis, Sherri Z., Gatalica, Zoran, Reddy, Sandeep, von Mehren, Margaret, Van Tine, Brian A.
Foilsithe in Oncotarget (2015)

Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma

le Robinson, Anthony M., Rathore, Richa, Redlich, Nathan J., Adkins, Douglas R., VanArsdale, Todd, Van Tine, Brian A., Michel, Loren S.
Foilsithe in Cell Death Dis (2019)

A Phase II Study of Tumor Ablation in Patients with Metastatic Sarcoma Stable on Chemotherapy

le Hirbe, Angela C., Jennings, Jack, Saad, Nael, Giardina, Joseph D., Tao, Yu, Luo, Jingqin, Berry, Shellie, Toeniskoetter, Jacqui, Van Tine, Brian A.
Foilsithe in Oncologist (2018)

A phase II clinical study of 13‐deoxy, 5‐iminodoxorubicin (GPX‐150) with metastatic and unresectable soft tissue sarcoma

le Van Tine, Brian A., Agulnik, Mark, Olson, Richard D., Walsh, Gerald M., Klausner, Arthur, Frank, Nicole E., Talley, Todd T., Milhem, Mohammed M.
Foilsithe in Cancer Med (2019)

Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming

le Brashears, Caitlyn B., Barlin, Meltem, Ehrhardt, William R., Rathore, Richa, Schultze, Matthew, Tzeng, Shin-Chen, Van Tine, Brian A., Held, Jason M.
Foilsithe in Cell Death Dis (2020)